Stratification of Biologic Therapies for Rheumatoid Arthritis (RA) by Pathobiology (STRAP)-EU: A randomised, open-labelled biopsy-driven stratification trial in DMARD inadequate responder patients randomised to Etanercept, Tocilizumab or Rituximab
Latest Information Update: 27 Apr 2023
Price :
$35 *
At a glance
- Drugs Rituximab (Primary) ; Etanercept; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms (STRAP)-EU
- 10 Jan 2021 Status changed from active, no longer recruiting to completed.
- 11 Dec 2020 Planned End Date changed from 19 Feb 2020 to 9 Jan 2021.
- 20 May 2019 New source identified and integrated ISRCTN: Current Controlled Trials